Ping J, Schildbach J F, Shaw S Y, Quertermous T, Novotny J, Bruccoleri R, Margolies M N
Department of Surgery, Massachusetts General Hospital, Boston 02114.
J Biol Chem. 1993 Nov 5;268(31):23000-7.
In certain instances, antibody variable region mutations outside of the antigen-combining site influence antigen binding. We reported previously that a heavy chain mutation (Ser-94-->Arg) decreased binding of the anti-digoxin antibody 40-150, whereas an additional signal peptide mutation at the -2 position (Gln-->Pro) causing NH2-terminal 2-residue truncation partially restored binding. To assess the combined effects on binding of two seemingly distant mutations, we constructed signal peptide mutations and NH2-terminal deletions in the presence of Ser-94 and Arg-94. Deletions of one to three amino acids had little effect on binding for Ser-94 mutants, whereas 2-residue truncations produced directly or by signal peptide mutation increased affinity approximately 40-fold for Arg-94 mutants. These observations are consistent with the reported computer-generated model of antibody 40-150. Introduction of Pro at the signal peptide -3 position in 40-150 resulted in cleavage at alternative sites, with varying effects on affinity. Introduction of Pro at -2 into the anti-digoxin antibody 26-10 resulted, unexpectedly, in expression of heavy chains with 3 extra NH2-terminal residues, causing an approximately 100-fold reduction in affinity. Thus, both extensions and deletions of the heavy chain amino terminus can enhance or reduce antigen binding, depending on the structural context of specific antigen combining sites.
在某些情况下,抗原结合位点之外的抗体可变区突变会影响抗原结合。我们之前报道过,一个重链突变(Ser-94→Arg)降低了抗地高辛抗体40-150的结合能力,而在-2位置的另一个信号肽突变(Gln→Pro)导致氨基末端2个残基截短,部分恢复了结合能力。为了评估两个看似相距较远的突变对结合的综合影响,我们在存在Ser-94和Arg-94的情况下构建了信号肽突变和氨基末端缺失。对于Ser-94突变体,缺失一到三个氨基酸对结合影响不大,而直接产生或通过信号肽突变产生的2个残基截短使Arg-94突变体的亲和力增加了约40倍。这些观察结果与报道的抗体40-150的计算机生成模型一致。在40-150的信号肽-3位置引入Pro导致在替代位点切割,对亲和力有不同影响。意外的是,在抗地高辛抗体26-10的-2位置引入Pro导致表达出具有3个额外氨基末端残基的重链,使亲和力降低了约100倍。因此,重链氨基末端的延长和缺失都可以增强或降低抗原结合,这取决于特定抗原结合位点的结构背景。